Depressive disorder is a neurological condition with possible inflammatory roots, according to doctors and researchers. HBOT's underlying mechanisms have long been identified to be potent antidotes for inflammation. A study released in May 2020 explored the use of HBOT to treat post-stroke depression, or PSD, a common after-effect of stroke.
In this meta-analysis, seven electronic databases were comprehensively searched for randomized clinical trials on HBOT through May 2019. Outcomes that were measured included response rate, depression severity, neurological deficit, physical disability, and adverse events experienced by HBOT patients. A total of 27 trials involving more than 2,000 participants were identified and reviewed in the analysis. Researchers stated that patients in HBOT groups had a higher response rate to depression treatment than patients in control groups. HBOT significantly reduced Hamilton Depression scores, National Institute of Health Stroke Scale scores, Chinese Stroke Scale scores, and Modified Scandinavian Stroke Scale scores. HBOT also improved the Barthel Index, which is often used to assess functional independence in stroke patients.
In treating patients who have recently suffered stroke, Hyperbaric Therapy of the Lowcountry staff has witnessed similar positive effects and improvmenent in patients who have undergone HBOT at its Hilton Head hyperbaric oxygen facility.
To read more: Hyperbaric Oxygen Therapy is Effective and Safe Therapeutic Approach for Post-Stroke Depression